Comprehensive molecular profiles of low-grade serous ovarian carcinoma

被引：0
|
作者：
ElNaggar, A. C. [1 ]
Robins, D. B. [1 ]
Arguello, D. [2 ]
Ulm, M. A. [1 ]
Mantia-Smaldone, G. M. [3 ]
Chu, C. [3 ]
Winer, I. [4 ]
Holloway, R. W. [5 ]
Krivak, T. C. [6 ]
Jones, N. L. [7 ]
Galvan-Turner, V. [8 ]
Herzog, T. J. [9 ]
Brown, J. [10 ]
机构：
[1] Univ Tennessee, West Canc Ctr, Memphis, TN USA
[2] Caris Life Sci, Irving, TX USA
[3] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[4] Wayne State Univ, Detroit, MI USA
[5] Florida Hosp Canc Inst, Orlando, FL USA
[6] Western Penn Hosp, Pittsburgh, PA 15224 USA
[7] Univ S Alabama, Mitchell Canc Inst, Mobile, AL USA
[8] WVU Healthcare, Morgantown, WV USA
[9] UC Hlth Barrett Canc Ctr, Cincinnati, OH USA
[10] Carolinas Med Ctr, Levine Canc Inst, Charlotte, NC 28203 USA
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.144
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1213
引用
收藏
页码：60 / 61
页数：3
相关论文
共 50 条
  • [31] Efficacy of Pegylated Liposomal Doxorubicin in Low-Grade Serous Ovarian Carcinoma
    Rose, Peter G.
    Radeva, Milena
    Michener, Chad M.
    Link, Nicholas
    Adbul-Karim, Fadi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (05) : 907 - 911
  • [32] Low-grade serous ovarian carcinoma is a rare histological subtype in Japan
    Iwahashi, Hideki
    Miyamoto, Morikazu
    Sakamoto, Takahiro
    Ishibashi, Hiroki
    Kakimoto, Soichiro
    Matsuura, Hiroko
    Tsuda, Hitoshi
    Takano, Masashi
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (06) : 1004 - 1009
  • [33] Quantification of ER/PR expression in ovarian low-grade serous carcinoma
    Escobar, Jorge
    Klimowicz, Alexander C.
    Dean, Michelle
    Chu, Pamela
    Nation, Jill G.
    Nelson, Gregg S.
    Ghatage, Prafull
    Kalloger, Steve E.
    Koebel, Martin
    GYNECOLOGIC ONCOLOGY, 2013, 128 (02) : 371 - 376
  • [34] Low-grade serous ovarian carcinoma: an evolution toward targeted therapy
    Voutsadakis, Ioannis A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (10) : 1619 - 1626
  • [35] Efficacy of pegylated liposomal doxorubicin in low-grade serous ovarian carcinoma
    Rose, P. G.
    Michener, C. M.
    Link, N. A.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 216 - 216
  • [36] Is invasive micropapillary serous carcinoma a low-grade serous carcinoma?
    Ohishi, Y.
    Aman, M.
    Oda, Y.
    VIRCHOWS ARCHIV, 2016, 469 : S110 - S110
  • [37] Genomic Analysis of Low-Grade Serous Ovarian Tumors Associated with High-Grade Serous Carcinoma or Undifferentiated Carcinoma
    Murali, Rajmohan
    Chandramohan, Raghu
    Soslow, Robert
    Cheng, Donavan
    McCluggage, W. Glenn
    LABORATORY INVESTIGATION, 2016, 96 : 298A - 298A
  • [38] Genomic Analysis of Low-Grade Serous Ovarian Tumors Associated with High-Grade Serous Carcinoma or Undifferentiated Carcinoma
    Murali, Rajmohan
    Chandramohan, Raghu
    Soslow, Robert
    Cheng, Donavan
    McCluggage, W. Glenn
    MODERN PATHOLOGY, 2016, 29 : 298A - 298A
  • [39] Low-Grade Serous Carcinoma of the Ovary
    Grisham, Rachel N.
    ONCOLOGY-NEW YORK, 2016, 30 (07): : 650 - 652
  • [40] COMPARATIVE STUDY OF OVARIAN LOW-GRADE AND HIGH-GRADE SEROUS OVARAIN CARCINOMA
    Mansouri, H.
    Zemni, I.
    Jaidane, O.
    Ayedi, M. A.
    Ben Hassouna, J.
    Hechiche, M.
    Chargui, R.
    Ben Rahal, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A116 - A117
12345